GeoVax director awarded 6,000 stock options
GeoVax Labs director Nicole Lemerond received a grant of 6,000 stock options for GeoVax Labs, Inc. common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
GeoVax Labs director Nicole Lemerond received a grant of 6,000 stock options for GeoVax Labs, Inc. common stock. These options were awarded at an exercise price of $1.18 per share and are scheduled to expire on June 17, 2036. Following this grant, she holds 6,000 derivative securities directly, reflecting a routine equity compensation award rather than an open-market purchase or sale.
Insider Trade Summary
Grant/Award: 6,000 shares
Grant/Award
1 txn
Insider
Lemerond Nicole
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option | 6,000 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option — 6,000 contracts (Direct)
Key Figures
Stock options granted: 6,000 options
Exercise price: $1.18 per share
Expiration date: June 17, 2036
+1 more
4 metrics
Stock options granted
6,000 options
Grant to director Nicole Lemerond
Exercise price
$1.18 per share
Strike price for granted options
Expiration date
June 17, 2036
Option term end
Derivative holdings after transaction
6,000 options
Total derivative securities following grant
Key Terms
Stock Option, exercise price, expiration date, Common Stock, +1 more
5 terms
Stock Option financial
"security_title: "Stock Option" with underlying Common Stock"
A stock option is a contract that gives you the right to buy or sell a company's stock at a specific price within a certain time frame. People use them to potentially make money if the stock's price moves favorably or to protect against losses. It's like holding a coupon that can be used to buy or sell stock at a set price later on.
exercise price financial
"conversion_or_exercise_price: "1.1800" per underlying share"
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date: "2036-06-17T00:00:00.000Z" for the option grant"
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
Common Stock financial
"underlying_security_title: "Common Stock" for the option"
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Form 4 regulatory
"INSIDER FILING DATA (Form 4) for GeoVax Labs, Inc."
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did GeoVax (GOVX) report for Nicole Lemerond?
GeoVax reported that director Nicole Lemerond received 6,000 stock options. These options give her the right to buy common shares at a fixed price, representing a routine equity compensation grant rather than an open-market trade.
What is the exercise price of Nicole Lemerond’s GeoVax (GOVX) stock options?
The stock options were granted with an exercise price of $1.18 per share. This means she can purchase GeoVax common stock at $1.18, regardless of the market price, any time before the options expire.
When do Nicole Lemerond’s GeoVax (GOVX) stock options expire?
The stock options are scheduled to expire on June 17, 2036. After this expiration date, any unexercised options will lapse, and she will no longer have the right to buy shares under this specific grant.
How many GeoVax (GOVX) derivative securities does Nicole Lemerond hold after this grant?
After the grant, she holds 6,000 derivative securities linked to GeoVax common stock. These represent stock options, not currently owned shares, and must be exercised at the $1.18 price to convert into common stock.
Was there any open-market buying or selling in this GeoVax (GOVX) Form 4?
No, the Form 4 shows a grant of 6,000 stock options as compensation. It does not report any open-market purchases or sales of GeoVax common stock by Nicole Lemerond in this transaction.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates